Key Financial’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-84
Closed -$2.1K – 1318
2026
Q2
$2.1K Hold
84
– – ﹤0.01% 1142
2026
Q1
$1.18K Hold
84
– – ﹤0.01% 1235
2025
Q4
$946 Sell
84
-7
-8% -$80 ﹤0.01% 1265
2025
Q3
$1.04K Sell
91
-401
-82% -$4.7K ﹤0.01% 1267
2025
Q2
$6.02K Hold
492
– – ﹤0.01% 995
2025
Q1
$7.05K Hold
492
– – ﹤0.01% 911
2024
Q4
$7.83K Hold
492
– – ﹤0.01% 875
2024
Q3
$11.8K Hold
492
– – ﹤0.01% 751
2024
Q2
$9.8K Hold
492
– – ﹤0.01% 787
2024
Q1
$9.8K Hold
492
– – ﹤0.01% 768
2023
Q4
$11K Hold
492
– – ﹤0.01% 713
2023
Q3
$9.9K Hold
492
– – ﹤0.01% 713
2023
Q2
$12.6K Hold
492
– – ﹤0.01% 669
2023
Q1
$14.6K Hold
492
– – 0.01% 599
2022
Q4
$10.7K Hold
492
– – 0.01% 612
2022
Q3
$11K Hold
492
– – 0.01% 603
2022
Q2
$14K Hold
492
– – 0.01% 561
2022
Q1
$16K Hold
492
– – 0.01% 535
2021
Q4
$17K Hold
492
– – 0.01% 508
2021
Q3
$15K Hold
492
– – 0.01% 508
2021
Q2
$19K Hold
492
– – 0.01% 475
2021
Q1
$22K Hold
492
– – 0.01% 385
2020
Q4
$23K Buy
+492
New +$20.5K 0.02% 352
2020
Q2
– Sell
-103
Closed -$3K – 132
2020
Q1
$3K Buy
+103
New +$3.08K ﹤0.01% 548

Other funds holding AVNS

Key Financial's AVNS Position: Q3 2026 in Review

Key Financial sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 84 shares — an estimated $2.1K sold.

Key Financial first reported a position in AVNS in Q1 2020 and held it in 24 quarters. The position peaked at $23K in Q4 2020. 2 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Key Financial reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Key Financial sold 84 Avanos Medical shares in Q3 2026, an estimated $2.1K.
  • Key Financial first reported a position in Avanos Medical in Q1 2020 and held it in 24 quarters.
  • Key Financial's Avanos Medical position peaked at $23K in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.